Enablemnt AI

Industries

Go-to-market for medical devices

We build the targeting, messaging and CRM to reach clinical and procurement buyers, and to survive the long, evidence-heavy cycles medical devices run on.

The challenge in Medical Devices

Medical devices sell into hospitals and health systems that buy slowly, through value-analysis committees, and demand clinical evidence before anyone signs. A device can be clearly better and still take a year or more to land.

The challenge is reaching the right clinical and economic buyers with evidence, navigating procurement and group purchasing contracts, and keeping a long, multi-stakeholder deal alive from first conversation to purchase order.

12–24 mo

typical medical device sales cycle

8–15

stakeholders: clinical, biomed, procurement, finance

Evidence + VAC

clinical evidence and value-analysis committees decide

Typical industry ranges from Gartner, Forrester, 6sense and sector reports. Figures vary by segment and deal size.

Who you're really selling to

A typical B2B purchase now involves six to ten decision-makers (Gartner), so we map and target the whole committee, not just the first person who replies. Here's who usually shapes a deal in Medical Devices.

1Clinician or department headChampion, judges clinical value
2Biomed or clinical engineeringGatekeeper on safety and integration
3Value-analysis committeeApproves on evidence and cost
4Procurement and GPONegotiate pricing and contracts
5Executive or finance sponsorApproves the budget

How Enablemnt wins in Medical Devices

We lead with clinical and economic evidence, because value-analysis committees buy on proof, not promises. Every target account is mapped across the clinicians who champion the device and the committee that approves it.

We account for the realities of hospital purchasing, GPO contracts, biomed sign-off and procurement, so outreach lands with the people who can actually move a device through the system.

Then we build a CRM designed for year-long cycles, with multichannel follow-up that keeps clinical champions and committees engaged until the purchase order lands.

  1. 01

    Lead with evidence

    Open with clinical and economic proof a value-analysis committee will accept.

  2. 02

    Map the committee

    Clinicians, biomed, procurement and finance, identified per account.

  3. 03

    Navigate procurement

    Account for GPO contracts and hospital purchasing from the start.

  4. 04

    Sustain the cycle

    A CRM and follow-up built to keep year-long deals alive.

What we build for you

Everything below is delivered inside the 14-day sprint, tuned for Medical Devices, and handed over fully documented.

  • A data-backed ideal customer profile and a scored list of medical device accounts, approved by you before any outreach
  • Verified, enriched contacts for the full medical device buying committee, deduped and loaded into your CRM
  • A CRM configured to how medical device deals actually progress, with the stages, properties and dashboards you need
  • Multichannel sequences written for medical device buyers and tested against their real objections before launch
  • Domain warm-up and SPF, DKIM and DMARC setup so your first send lands in the inbox, not spam
  • A documented playbook and a recorded handoff, so your team owns and can run the whole system

Signals you'll recognise

If a few of these sound familiar, you're the kind of team a sprint is built for.

  • Value-analysis committees and long approval cycles
  • Evidence and procurement hurdles before any purchase
  • No CRM to track a year-long, multi-stakeholder deal

Why speed matters in Medical Devices

In medical devices, the deals that close next year are the relationships and evidence you put in front of the right committees now.

The sprint builds that foundation in two weeks: evidence-led targeting, committee mapping and a CRM made for long, regulated cycles.

Frequently asked questions

Device cycles take a year or more. Is outbound worth it?
Yes. The sooner the right clinicians and committees are engaged and tracked, the sooner long cycles close. We build the evidence-led outreach and the CRM to run them.

Ready to go to market in 14 days?

Tell us about your startup and we'll map your GTM blueprint on a short call.